当前位置:首页 - 行情中心 - 晨光生物(300138) - 财务分析

晨光生物

(300138)

  

流通市值:52.14亿  总市值:63.24亿
流通股本:3.98亿   总股本:4.83亿

晨光生物(300138)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润2.21亿元,每股收益0.44元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益331022.54万元,未分配利润204423.88万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产929907.39万元,负债598884.85万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入3,657,547,726.711,716,472,687.326,994,192,786.235,225,428,968.08
营业总成本3,432,495,143.031,605,425,014.26,868,044,529.725,127,064,914.93
其他经营收益
营业利润263,968,367.45129,813,643.12106,035,576.7160,260,728.27
利润总额264,861,158.21131,283,325.59106,945,324.7174,352,639.96
净利润221,253,745.12111,187,387.9477,957,113.4945,240,156.78
每股收益
其他综合收益-2,914,508.54-807,209.723,336,226.69-6,507,503.31
综合收益总额218,339,236.58110,380,178.2281,293,340.1838,732,653.47
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计7,112,389,019.288,093,880,839.236,808,992,375.285,565,427,092.55
非流动资产:
非流动资产合计2,186,684,857.882,203,548,131.832,213,528,285.322,184,311,145.62
资产总计9,299,073,877.1610,297,428,971.069,022,520,660.67,749,738,238.17
流动负债:
流动负债合计5,589,174,757.485,762,603,349.894,596,089,600.873,118,704,931.42
非流动负债:
非流动负债合计399,673,716.281,269,756,264.051,271,741,880.821,522,286,736.57
负债合计5,988,848,473.767,032,359,613.945,867,831,481.694,640,991,667.99
所有者权益(或股东权益):
归属于母公司股东权益合计3,258,743,076.143,218,162,338.763,109,489,222.53,065,164,116.02
股东权益合计3,310,225,403.43,265,069,357.123,154,689,178.913,108,746,570.18
负债和股东权益合计9,299,073,877.1610,297,428,971.069,022,520,660.67,749,738,238.17
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计4,098,466,852.611,918,596,958.417,878,741,829.315,316,694,895.19
经营活动现金流出小计2,268,730,213.271,388,152,550.448,101,556,789.283,713,508,286.09
经营活动产生的现金流量净额1,829,736,639.34530,444,407.97-222,814,959.971,603,186,609.1
投资活动产生的现金流量:
投资活动现金流入小计1,793,627,155.661,098,489,002.421,060,378,235.151,166,862,948.64
投资活动现金流出小计3,116,472,382.252,575,097,320.261,501,333,221.32951,658,165.1
投资活动产生的现金流量净额-1,322,845,226.59-1,476,608,317.84-440,954,986.17215,204,783.54
筹资活动产生的现金流量:
筹资活动现金流入小计1,965,690,035.91,505,278,154.265,783,439,209.463,668,038,020.2
筹资活动现金流出小计1,730,533,463.36335,287,014.635,679,638,840.944,239,603,024.86
筹资活动产生的现金流量净额235,156,572.541,169,991,139.63103,800,368.52-571,565,004.66
汇率变动对现金及现金等价物的影响-2,226,398.82-2,338,013.84-10,493,145.08-6,716,726.56
现金及现金等价物净增加额739,821,586.47221,489,215.92-570,462,722.71,240,109,661.42
期末现金及现金等价物余额1,254,623,826.49736,291,455.94514,802,240.022,325,374,624.14
补充资料:
现金及现金等价物的净增加额739,821,586.47--570,462,722.7-
最新报告期:2025-09-02
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西南证券朱会振,杜雨聪0.751.001.312025-09-02
浙商证券钟烨晨0.680.841.032025-08-28
中邮证券王琦0.710.961.122025-08-28
申万宏源吕昌0.670.841.062025-08-26
华泰证券倪欣雨0.740.961.162025-08-26
TOP↑